In preparation for future clinical trials, we have demonstrated that treatment with HED of l-DOPA that are already in established use for children with infantile dystonia and amblyopia from 15 days PNA, can rescue retinal morphology and visual function in OCA1 mice. The gene discussed is TYR; the disease is hypohidrotic ectodermal dysplasia.